Utility of walk tests in progression of mild COVID-19 infection at a tertiary hospital in North India.
Recent Adv Antiinfect Drug Discov
; 2022 Jun 30.
Article
in English
| MEDLINE | ID: covidwho-1923831
ABSTRACT
INTRODUCTION:
There have been 214 million confirmed cases of COVID-19 worldwide with a total death tally of 4.4 million. The current study aims to determine the predictive value of various scores in assessment of progression of mild COVID-19 infection at a tertiary care hospital in North India.METHODS:
The study population consisted of adults (age more than 18 years) with a confirmed diagnosis of COVID-19 by RT-PCR on nasopharyngeal specimens. Patients with only mild illness were enrolled. After the patients were admitted to the isolation ward, the presenting history, comorbidity status, vital signs and laboratory parameters were recorded. The 3 and 6 minute walk test was performed daily from admission till discharge or progression of severity of COVID-19 and it was used to calculate Borg dyspnoea score (BDS) and National Early Warning Score (NEWS2) scores.RESULTS:
Our study consisted of 50 patients with 34 (68%) males and the mean (SD) age of the patient population being 28.1 (6.4) years. The most common symptoms were fever, sore throat, and cough. All laboratory parameters were within normal ranges for all the patients. 96% recovered without progression, while only 4% of them progressed to moderate illness. Results of the 3 and 6 minutes walk tests, BDS and NEWS2 scores showed improvement over the course of hospital stay.CONCLUSIONS:
Although the walk tests and the scores improved over time, they failed to predict the disease progression.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Language:
English
Year:
2022
Document Type:
Article
Affiliation country:
2772434417666220630112737
Similar
MEDLINE
...
LILACS
LIS